{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:12:15Z","timestamp":1767651135935,"version":"3.44.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.amjsurg.2003.03.006","type":"journal-article","created":{"date-parts":[[2003,12,31]],"date-time":"2003-12-31T07:17:39Z","timestamp":1072855059000},"page":"134-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["A consensus statement on empiric therapy for suspected gram-positive infections in surgical patients"],"prefix":"10.1016","volume":"187","author":[{"given":"Joseph S","family":"Solomkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.Stephen","family":"Bjornson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Cainzos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.Patchen","family":"Dellinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Dominioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Eidus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Faist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Leaper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James T","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela A","family":"Lipsett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl L","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Weigelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel Eric","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjsurg.2003.03.006_BIB1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/520192","article-title":"Nosocomial bloodstream infections in United States hospitals","volume":"29","author":"Edmond","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB2","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1086\/501795","article-title":"Nosocomial infections in combined medical-surgical intensive care units in the United States","volume":"21","author":"Richards","year":"2000","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0732-8893(98)00108-4","article-title":"Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant Gram-positive bacteria","volume":"33","author":"Jones","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1378\/chest.113.2.412","article-title":"The influence of mini-BAL cultures on patient outcomes","volume":"113","author":"Kollef","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB5","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/clinids\/23.3.486","article-title":"Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy","volume":"23","author":"Montravers","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/0003-4819-115-8-585","article-title":"Enterobacter bacteremia","volume":"115","author":"Chow","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB7","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/clinids\/21.6.1417","article-title":"Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus","volume":"21","author":"Romero-Vivas","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2796.1998.00379.x","article-title":"The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection","volume":"244","author":"Leibovici","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1128\/AAC.29.1.85","article-title":"Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus","volume":"29","author":"Hartman","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB10","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1128\/AAC.36.12.2617","article-title":"Survey of the methicillin resistance-associated genes mecA, mecR1-mecI, and femA-femB in clinical isolates of methicillin-resistant Staphylococcus aureus","volume":"36","author":"Hurlimann-Dalel","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/40.1.135","article-title":"Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility","volume":"40","author":"Hiramatsu","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJM199902183400701","article-title":"Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group","volume":"340","author":"Smith","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB13","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(97)07324-8","article-title":"Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin","volume":"350","author":"Hiramatsu","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB14","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(99)01017-X","article-title":"Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin","volume":"353","author":"Ariza","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1128\/AAC.42.1.100","article-title":"Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci","volume":"42","author":"Sieradzki","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB16","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJM200012283432604","article-title":"Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients","volume":"343","author":"Donskey","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB17","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1001\/jama.287.18.2351-JMN0508-2-1","article-title":"CDC campaign targets antimicrobial resistance in hospitals","volume":"287","author":"Stephenson","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB18","first-page":"438","article-title":"Guideline for prevention of intravascular device-related infections. Hospital Infection Control Practices Advisory Committee","volume":"17","author":"Pearson","year":"1996","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/501620","article-title":"Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee","volume":"20","author":"Mangram","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB20","doi-asserted-by":"crossref","first-page":"177S","DOI":"10.1378\/chest.117.4_suppl_2.177S","article-title":"Evidence-based assessment of diagnostic tests for ventilator-associated pneumonia. Executive summary","volume":"117","author":"Grossman","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.118.1.146","article-title":"The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting","volume":"118","author":"Ibrahim","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0924-8579(99)00147-8","article-title":"Risk factors influencing clinical outcome in Staphylococcus aureus bacteraemia in a Turkish University Hospital","volume":"14","author":"Topeli","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB23","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archinte.1995.00430110069007","article-title":"Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters","volume":"155","author":"Malanoski","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB24","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1086\/320001","article-title":"Guidelines for the management of intravascular catheter-related infections","volume":"32","author":"Mermel","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB25","first-page":"582","article-title":"Methicillin-resistant Staphylococcus aureus in U.S","volume":"13","author":"Panlilio","year":"1992","journal-title":"hospitals, 1975-1991. Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/320869","article-title":"Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers","volume":"33","author":"Fortun","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"suppl 5","key":"10.1016\/j.amjsurg.2003.03.006_BIB27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/1120009X.2000.11782314","article-title":"Comparative safety of teicoplanin and vancomycin","volume":"12","author":"Wood","year":"2000","journal-title":"J Chemother"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB28","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/AAC.43.7.1549","article-title":"Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity","volume":"43","author":"Rybak","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB29","first-page":"155","article-title":"Recent developments in streptogramin research","volume":"4","author":"Barriere","year":"1998","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB30","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2165\/00003495-199958060-00008","article-title":"Quinupristin\/dalfopristin","volume":"58","author":"Lamb","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0149-2918(01)80028-X","article-title":"Quinupristin\/dalfopristin","volume":"23","author":"Allington","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB32","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1128\/AAC.41.10.2132","article-title":"Mechanism of action of oxazolidinones","volume":"41","author":"Shinabarger","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/jac\/47.1.77","article-title":"In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates","volume":"47","author":"Cercenado","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB34","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1128\/AAC.43.8.2059","article-title":"In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci","volume":"43","author":"Noskin","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/jac\/45.2.225","article-title":"Activity of linezolid against multi-resistant gram-positive bacteria from diverse hospitals in the United Kingdom","volume":"45","author":"Johnson","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/jac\/43.4.569","article-title":"Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin\/dalfopristin and linezolid against staphylococci","volume":"43","author":"von Eiff","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0732-8893(99)00016-4","article-title":"In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae","volume":"34","author":"Patel","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"suppl 4","key":"10.1016\/j.amjsurg.2003.03.006_BIB38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1086\/314080","article-title":"Emerging therapies for serious gram-positive bacterial infections","volume":"31","author":"Plouffe","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB39","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1086\/318486","article-title":"Linezolid","volume":"32","author":"Rubinstein","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB40","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1128\/AAC.46.8.2723-2726.2002","article-title":"Hematologic effects of linezolid","volume":"46","author":"Gerson","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB41","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/0003-4819-115-9-674","article-title":"Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis","volume":"115","author":"Levine","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB42","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1128\/AAC.34.6.1227","article-title":"Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users","volume":"34","author":"Small","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB43","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3109\/00365549509047061","article-title":"Protracted and recurrent methicillin-resistant Staphylococcus aureus bacteremia despite defervescence with vancomycin therapy","volume":"27","author":"Khatib","year":"1995","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(00)03572-8","article-title":"Effect of vancomycin and rifampicin on meticillin-resistant Staphylococcus aureus biofilms","volume":"357","author":"Jones","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s002689900359","article-title":"Antibiotic-resistant gram-positive cocci","volume":"22","author":"Barie","year":"1998","journal-title":"World J Surg"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB46","doi-asserted-by":"crossref","first-page":"N82","DOI":"10.1097\/00003246-200104001-00005","article-title":"Impact of Gram-positive resistance on outcome of nosocomial pneumonia","volume":"29","author":"Bodi","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB47","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/313440","article-title":"Bacteremic pneumonia due to Staphylococcus aureus","volume":"29","author":"Gonzalez","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"10.1016\/j.amjsurg.2003.03.006_BIB48","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0924-8579(00)00303-4","article-title":"Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections","volume":"16","author":"Moise","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB49","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1086\/646433","article-title":"A comparison of clinical virulence of nosocomially acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus infections in a university hospital","volume":"13","author":"Hershow","year":"1992","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01690549","article-title":"Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteriemic cancer patients","volume":"19","author":"Marty","year":"1993","journal-title":"Intens Care Med"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/345476","article-title":"Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia","volume":"36","author":"Cosgrove","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/647704","article-title":"Risk factors for mortality in Staphylococcus aureus bacteremia","volume":"19","author":"Conterno","year":"1998","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB53","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1086\/501641","article-title":"Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia","volume":"20","author":"Abramson","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3201\/eid0501.990102","article-title":"The economic impact of Staphylococcus aureus infection in New York City hospitals","volume":"5","author":"Rubin","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/jac\/42.2.189","article-title":"Glycopeptide tolerance in Staphylococcus aureus","volume":"42","author":"May","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB56","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1128\/AAC.38.4.724","article-title":"Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus","volume":"38","author":"Ryffel","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB57","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1086\/520429","article-title":"Bacteremia caused by staphylococci with inducible vancomycin heteroresistance","volume":"29","author":"Wong","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB58","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-198407000-00005","article-title":"Antibiotic trials in intra-abdominal infections. A critical evaluation of study design and outcome reporting","volume":"200","author":"Solomkin","year":"1984","journal-title":"Ann Surg"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB59","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1128\/AAC.31.5.808","article-title":"Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci","volume":"31","author":"Najjar","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB60","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1172\/JCI106758","article-title":"Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci","volume":"50","author":"Moellering","year":"1971","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB61","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1128\/jb.167.2.631-638.1986","article-title":"Nucleotide sequence analysis of the gene specifying the bifunctional 6","volume":"167","author":"Ferretti","year":"1986","journal-title":"J Bacteriol"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB62","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.mi.49.100195.002055","article-title":"Conjugative transposition","volume":"49","author":"Scott","year":"1995","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB63","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1099\/00221287-146-6-1481","article-title":"Characterization of transposon Tn1549, conferring VanB-type resistance in Enterococcus spp","volume":"146","author":"Garnier","year":"2000","journal-title":"Microbiology"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB64","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1074-5521(99)89009-7","article-title":"Mutational analysis of active-site residues of the enterococcal D-ala-D-Ala dipeptidase VanX and comparison with Escherichia coli D-ala-D-Ala ligase and D-ala-D-Ala carboxypeptidase VanY","volume":"6","author":"Lessard","year":"1999","journal-title":"Chem Biol"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB65","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1099\/00222615-47-10-849","article-title":"Glycopeptide-resistant enterococci","volume":"47","author":"Woodford","year":"1998","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB66","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/520311","article-title":"Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia","volume":"26","author":"Lucas","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB67","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/501624","article-title":"Enterococcal bacteremia","volume":"20","author":"Lautenbach","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB68","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1086\/344177","article-title":"Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium","volume":"35","author":"Pai","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB69","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","article-title":"Linezolid resistance in a clinical isolate of Staphylococcus aureus","volume":"358","author":"Tsiodras","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB70","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1517\/14656566.2.2.293","article-title":"Linezolid\u2014a review of the first oxazolidinone","volume":"2","author":"Norrby","year":"2001","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB71","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2165\/00003495-200161040-00008","article-title":"Linezolid","volume":"61","author":"Perry","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB72","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3949\/ccjm.69.5.397","article-title":"Two new treatment options for infections due to drug-resistant gram-positive cocci","volume":"69","author":"Rehm","year":"2002","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB73","first-page":"71","article-title":"Cost considerations in the evaluation of new therapies for gram-positive bacteria","volume":"13","author":"Nathwani","year":"1999","journal-title":"Int J Antimicrob Agents"},{"issue":"suppl A","key":"10.1016\/j.amjsurg.2003.03.006_BIB74","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/44.suppl_1.31","article-title":"Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci","volume":"44","author":"Carbon","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB75","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1592\/phco.21.3.263.34198","article-title":"Comparison of length of hospital stay for patients with known or suspected methicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin","volume":"21","author":"Li","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB76","first-page":"540","article-title":"Effects of linezolid on hospital length of stay compared with vancomycin in treatment of methicillin-resistant Staphylococcus infections. An application of multivariate survival analysis","volume":"18","author":"Willke","year":"2002","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB77","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1464-5491.1999.00132.x","article-title":"Methicillin-resistant Staphylococcus aureus","volume":"16","author":"Tentolouris","year":"1999","journal-title":"Diabet Med"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB78","first-page":"27","article-title":"Methi-resistant Staphylococcus aureus in dermatological practice","volume":"129","author":"Trividic","year":"2002","journal-title":"Ann Dermatol Venereol"},{"issue":"suppl 6","key":"10.1016\/j.amjsurg.2003.03.006_BIB79","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2165\/00003495-199700546-00004","article-title":"Colonisation and infection with resistant gram-positive cocci. Epidemiology and risk factors","volume":"54","author":"Cars","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB80","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00003495-199855030-00001","article-title":"Risk factors for the spread of antibiotic-resistant bacteria","volume":"55","author":"Rao","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB81","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1086\/313454","article-title":"Methicillin-resistant Staphylococcus aureus as a causative agent of postoperative intra-abdominal infection","volume":"29","author":"Fierobe","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB82","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/jhin.1998.0543","article-title":"Analysis of risk factors associated with nosocomial bacteraemias","volume":"42","author":"Rojo","year":"1999","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB83","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1001\/archinte.159.13.1437","article-title":"Risk factors for hospital-acquired Staphylococcus aureus bacteremia","volume":"159","author":"Jensen","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB84","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00000441-200203000-00001","article-title":"Risk factors for methicillin-resistance among patients with Staphylococcus aureus bacteremia at the time of hospital admission","volume":"323","author":"Rezende","year":"2002","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB85","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/archinte.159.11.1244","article-title":"Staphylococcus aureus bacteremia among elderly vs younger adult patients","volume":"159","author":"McClelland","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB86","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1086\/317421","article-title":"Staphylococcus aureus bacteremia","volume":"31","author":"Mylotte","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB87","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1086\/647870","article-title":"Spread of vancomycin-resistant enterococci","volume":"19","author":"Martone","year":"1998","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB88","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/jhin.1999.0750","article-title":"Workload may be related to the spread of MRSA and other infections","volume":"45","author":"Bignardi","year":"2000","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB89","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/archsurg.133.12.1343","article-title":"Third-generation cephalosporins and vancomycin as risk factors for postoperative vancomycin-resistant enterococcus infection","volume":"133","author":"Dahms","year":"1998","journal-title":"Arch Surg"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB90","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/106002809603000610","article-title":"Vancomycin-resistant enterococci","volume":"30","author":"Gin","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB91","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/501880","article-title":"A hospital epidemic of vancomycin-resistant Enterococcus","volume":"22","author":"Byers","year":"2001","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB92","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1053\/jhin.1998.0641","article-title":"Rectal colonization with vancomycin-resistant enterococci among high-risk patients in an Israeli hospital","volume":"43","author":"Dan","year":"1999","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB93","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1378\/chest.115.4.1085","article-title":"The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients","volume":"115","author":"Bhorade","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB94","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/archinte.158.5.522","article-title":"Enterococcus faecium bacteremia","volume":"158","author":"Stosor","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB95","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0732-8893(98)00148-5","article-title":"Vancomycin-resistant enterococci","volume":"33","author":"Linden","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB96","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1086\/501623","article-title":"Control of transmission of vancomycin-resistant Enterococcus faecium in a long-term-care facility","volume":"20","author":"Armstrong-Evans","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB97","first-page":"129","article-title":"Antimicrobial resistance in long-term-care facilities","volume":"17","author":"Strausbaugh","year":"1996","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB98","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1001\/archinte.158.10.1127","article-title":"The role of \u201ccolonization pressure\u201d in the spread of vancomycin-resistant enterococci","volume":"158","author":"Bonten","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjsurg.2003.03.006_BIB99","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1097\/00003246-199812000-00029","article-title":"External sources of vancomycin-resistant enterococci for intensive care units","volume":"26","author":"Bonten","year":"1998","journal-title":"Crit Care Med"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961003004549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961003004549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T17:35:02Z","timestamp":1757698502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961003004549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0002961003004549"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2003.03.006","relation":{},"ISSN":["0002-9610"],"issn-type":[{"type":"print","value":"0002-9610"}],"subject":[],"published":{"date-parts":[[2004,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A consensus statement on empiric therapy for suspected gram-positive infections in surgical patients","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2003.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}